Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 3/20 | 0.40 |
| ▸ | DRD3 | P35462 | 3/20 | 0.40 |
| ▸ | CNR1 | P21554 | 2/20 | 0.39 |
| ▸ | CNR2 | P34972 | 2/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.38 |
| ▸ | TNF | P01375 | 1/20 | 0.36 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.36 |
| ▸ | P4HB | P07237 | 2/20 | 0.36 |
| ▸ | APLNR | P35414 | 2/20 | 0.36 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22664587 | 0.88 | DRD2 (0.42) | DRD2DRD3CNR1CNR2S1PR1 | |
| SCHEMBL19003708 | 0.88 | DRD2 (0.42) | DRD2DRD3CNR1CNR2S1PR1 | |
| SCHEMBL14518608 | 0.84 | S1PR1 (0.41) | DRD2DRD3CNR1CNR2S1PR1 | |
| SCHEMBL18557399 | 0.82 | NR1I2 (0.43) | DRD2DRD3CNR1CNR2S1PR1 | |
| SCHEMBL22432045 | 0.80 | CNR1 (0.46) | DRD2DRD3CNR1CNR2S1PR1 | |
| SCHEMBL19707534 | 0.80 | GRM4 (0.43) | DRD2DRD3CNR1CNR2S1PR1 | |
| SCHEMBL20372845 | 0.78 | S1PR1 (0.41) | DRD2DRD3CNR1CNR2S1PR1 | |
| SCHEMBL12488294 | 0.77 | S1PR1 (0.45) | DRD2DRD3CNR1CNR2S1PR1 | |
| SCHEMBL9646900 | 0.76 | MAPK1 (0.43) | DRD2DRD3CNR1CNR2S1PR1 | |
| SCHEMBL20963206 | 0.75 | TNF (0.36) | CNR1CNR2S1PR1TNFGRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9662335-B2 | Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus kinase inhibitors | INCYTE HOLDINGS CORPORATION (US) | 2017-05-30 | — | — | US | disclosed |